<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0235">
 <label>47</label>
 <element-citation publication-type="journal" id="h0235">
  <person-group person-group-type="author">
   <name>
    <surname>Frobert</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Gotberg</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Angeras</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Jonasson</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Erlinge</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Engstrom</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial</article-title>
  <source>Am Heart J</source>
  <year>2017;189:94â€“102.</year>
  <pub-id pub-id-type="doi">10.1016/j.ahj.2017.04.003</pub-id>
 </element-citation>
</ref>
